TITLE

A strong root for stem cells

AUTHOR(S)
Goldman, Steve
PUB. DATE
April 2005
SOURCE
Nature Cell Biology;Apr2005, Vol. 7 Issue 4, p341
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
No abstract available.
ACCESSION #
16621790

 

Related Articles

  • Review Handbook of Stem Cells, Second Edition, A. Atala & R. Lanza. Mazzoni, Esteban O. // DNA & Cell Biology;Jan2014, Vol. 33 Issue 1, p57 

    The article reviews the book "Handbook of Stem Cells 2nd edition" edited by Anthony Atala and Robert Lanza.

  • MAIL. Baker, Theo; Carrigg, Dan; Smith, Robert J.; Simpson, Joe E.; Lawrence, Tony; Merkle, Toby; Myer, Larry; Nolan, Richard; Baumgartner, Tim // Discover;Nov2008, Vol. 29 Issue 11, p7 

    Several letters to the editor are presented in response to articles including "Inside Out: A DNA Diary," "The Vatican's Holy Alliance," and an interview with Robert Lanza in the September 2008 issue.

  • Simple protein helps human embryonic stem cells to thrive. Coghlan, Andy // New Scientist;1/19/2008, Vol. 197 Issue 2639, p13 

    This article reports that Robert Lanza of Advanced Cell Technology of Worcester, Massachusetts succeeded in creating human embryonic stem cells (hESCs) without destroying a human embryo in January, 2008 by adding laminin to blastomeres extracted from embryos.

  • Therapies come closer with 'cleaner' stem cell lines. Singer, Emily // Nature Medicine;Apr2005, Vol. 11 Issue 4, p357 

    Reports on scientists' development of a line of human stem cells without using animal cells, a potential source of contaminants. Concerns over the clinical use of animal cells; Robert Lanza and colleagues at Advanced Cell Technology's development of a cell line free of any animal cells or serum.

  • Stem cells derived without destruction of embryos. Bhojwani, Jyoti // Current Science (00113891);12/25/2006, Vol. 91 Issue 12, p1597 

    The article presents a letter which comments on the findings of a study by a research group from Advanced Cell Technology in Worcester, Massachusetts, led by Robert Lanza, which claimed that embryonic stem cells can be obtained for therapeutic use and other important applications without the...

  • Study Suggests Fountain of Youth Cells Age Prematurely. Breindl, Anette // BioWorld Today;2/12/2010, Vol. 21 Issue 29, p1 

    The article discusses research on induced pluripotent stem (iPS) cells. It references a study by a team led by Robert Lanza and published in the February 11, 2010 online edition of "Stem Cells." According to the study, these iPC cells, which are considered Fountain of Youth cells, age...

  • ACT Announces Europe's First Human Embryonic Stem Cell Transplant in Patient with Stargardt's Disease.  // Biomedical Market Newsletter;1/28/2012, Vol. 21, p1 

    The article reports on an announcement made by Advanced Cell Technology Inc. (ACT) regarding first human embryonic stem cell transplant in a patient with Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells. According to Robert Lanza, chief scientific officer of ACT,...

  • Stem-cell breakthrough may resolve the impasse.  // Contemporary Pediatrics;Oct2006, Vol. 23 Issue 10, p16 

    This article offers information on a report released by Robert Lanza, medical doctor of Advanced Cell Technology, about a new technique for growing a stem-cell line. According to Lanza, his technique would grow a stem-cell line from a single embryonic cell that is removed from frozen, eight-cell...

  • Big red boost for artificial blood. Coghlan, Andy // New Scientist;8/23/2008, Vol. 199 Issue 2670, p10 

    The article focuses on the issue concerning the mass production of the blood type-O negative. It notes the potential of the creation of blood from human embryonic stem cells (ESCs) to aid in combating disease transmission. It also cites the success of the Robert Lanza and his colleagues at the...

Share

Other Topics